Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders

M. Kawakita, Y. Yonemura, H. Miyake, T. Ohkubo, N. Asou, K. Hayakawa, M. Nakamura, T. Kitoh, H. Osawa, K. Takatsuki, T. Suda

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The proto-oncogene, c-kit, encodes a transmembrane tyrosine kinase receptor (KIT) and plays an important role in haemopoiesis. We have identified a 95 kD soluble form of KIT (S-KIT) in culture supernatant of human megakaryoblastic cell line, CMK. To study the physiological significance of S-KIT, we have established a sensitive sandwich ELISA system. Serum samples from healthy individuals contained detectable amounts of S-KIT. Next, we determined a total of 220 samples from 134 patients with haemopoietic disorders. A considerable number of patients with acute myeloid leukaemia (AML), especially those with more immature phenotypes (MO, M1 or M2) had elevated levels of serum S-KIT. Those levels decreased to the normal range after effective chemotherapy. In chronic myeloid leukaemia, patients with myeloid blastic crisis showed markedly elevated levels of serum S-KIT. In contrast, S-KIT levels decreased in cases with either acute or chronic lymphoid leukaemia. There was a tendency for patients with severe aplastic anaemia to show decreased levels, but it was not significant. In myelodysplastic syndrome, S-KIT levels appeared to vary by subsets, with higher concentration in more advanced forms of the disease. Although the functional role of S-KIT is not yet elucidated, these results suggest that the serum S-KIT levels may reflect the pathological states of various haematological disorders.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalBritish Journal of Haematology
Volume91
Issue number1
Publication statusPublished - 1995

Fingerprint

Serum
Lymphoid Leukemia
Proto-Oncogenes
Aplastic Anemia
Myelodysplastic Syndromes
Receptor Protein-Tyrosine Kinases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Acute Myeloid Leukemia
Reference Values
Phosphotransferases
Enzyme-Linked Immunosorbent Assay
Phenotype
Drug Therapy
Cell Line

Keywords

  • CMK
  • Haemopoietic disorders
  • Human sera
  • Soluble c-kit products

ASJC Scopus subject areas

  • Hematology

Cite this

Kawakita, M., Yonemura, Y., Miyake, H., Ohkubo, T., Asou, N., Hayakawa, K., ... Suda, T. (1995). Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders. British Journal of Haematology, 91(1), 23-29.

Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders. / Kawakita, M.; Yonemura, Y.; Miyake, H.; Ohkubo, T.; Asou, N.; Hayakawa, K.; Nakamura, M.; Kitoh, T.; Osawa, H.; Takatsuki, K.; Suda, T.

In: British Journal of Haematology, Vol. 91, No. 1, 1995, p. 23-29.

Research output: Contribution to journalArticle

Kawakita, M, Yonemura, Y, Miyake, H, Ohkubo, T, Asou, N, Hayakawa, K, Nakamura, M, Kitoh, T, Osawa, H, Takatsuki, K & Suda, T 1995, 'Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders', British Journal of Haematology, vol. 91, no. 1, pp. 23-29.
Kawakita M, Yonemura Y, Miyake H, Ohkubo T, Asou N, Hayakawa K et al. Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders. British Journal of Haematology. 1995;91(1):23-29.
Kawakita, M. ; Yonemura, Y. ; Miyake, H. ; Ohkubo, T. ; Asou, N. ; Hayakawa, K. ; Nakamura, M. ; Kitoh, T. ; Osawa, H. ; Takatsuki, K. ; Suda, T. / Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders. In: British Journal of Haematology. 1995 ; Vol. 91, No. 1. pp. 23-29.
@article{c6d08a93258d47e78edff2533ae03a44,
title = "Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders",
abstract = "The proto-oncogene, c-kit, encodes a transmembrane tyrosine kinase receptor (KIT) and plays an important role in haemopoiesis. We have identified a 95 kD soluble form of KIT (S-KIT) in culture supernatant of human megakaryoblastic cell line, CMK. To study the physiological significance of S-KIT, we have established a sensitive sandwich ELISA system. Serum samples from healthy individuals contained detectable amounts of S-KIT. Next, we determined a total of 220 samples from 134 patients with haemopoietic disorders. A considerable number of patients with acute myeloid leukaemia (AML), especially those with more immature phenotypes (MO, M1 or M2) had elevated levels of serum S-KIT. Those levels decreased to the normal range after effective chemotherapy. In chronic myeloid leukaemia, patients with myeloid blastic crisis showed markedly elevated levels of serum S-KIT. In contrast, S-KIT levels decreased in cases with either acute or chronic lymphoid leukaemia. There was a tendency for patients with severe aplastic anaemia to show decreased levels, but it was not significant. In myelodysplastic syndrome, S-KIT levels appeared to vary by subsets, with higher concentration in more advanced forms of the disease. Although the functional role of S-KIT is not yet elucidated, these results suggest that the serum S-KIT levels may reflect the pathological states of various haematological disorders.",
keywords = "CMK, Haemopoietic disorders, Human sera, Soluble c-kit products",
author = "M. Kawakita and Y. Yonemura and H. Miyake and T. Ohkubo and N. Asou and K. Hayakawa and M. Nakamura and T. Kitoh and H. Osawa and K. Takatsuki and T. Suda",
year = "1995",
language = "English",
volume = "91",
pages = "23--29",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders

AU - Kawakita, M.

AU - Yonemura, Y.

AU - Miyake, H.

AU - Ohkubo, T.

AU - Asou, N.

AU - Hayakawa, K.

AU - Nakamura, M.

AU - Kitoh, T.

AU - Osawa, H.

AU - Takatsuki, K.

AU - Suda, T.

PY - 1995

Y1 - 1995

N2 - The proto-oncogene, c-kit, encodes a transmembrane tyrosine kinase receptor (KIT) and plays an important role in haemopoiesis. We have identified a 95 kD soluble form of KIT (S-KIT) in culture supernatant of human megakaryoblastic cell line, CMK. To study the physiological significance of S-KIT, we have established a sensitive sandwich ELISA system. Serum samples from healthy individuals contained detectable amounts of S-KIT. Next, we determined a total of 220 samples from 134 patients with haemopoietic disorders. A considerable number of patients with acute myeloid leukaemia (AML), especially those with more immature phenotypes (MO, M1 or M2) had elevated levels of serum S-KIT. Those levels decreased to the normal range after effective chemotherapy. In chronic myeloid leukaemia, patients with myeloid blastic crisis showed markedly elevated levels of serum S-KIT. In contrast, S-KIT levels decreased in cases with either acute or chronic lymphoid leukaemia. There was a tendency for patients with severe aplastic anaemia to show decreased levels, but it was not significant. In myelodysplastic syndrome, S-KIT levels appeared to vary by subsets, with higher concentration in more advanced forms of the disease. Although the functional role of S-KIT is not yet elucidated, these results suggest that the serum S-KIT levels may reflect the pathological states of various haematological disorders.

AB - The proto-oncogene, c-kit, encodes a transmembrane tyrosine kinase receptor (KIT) and plays an important role in haemopoiesis. We have identified a 95 kD soluble form of KIT (S-KIT) in culture supernatant of human megakaryoblastic cell line, CMK. To study the physiological significance of S-KIT, we have established a sensitive sandwich ELISA system. Serum samples from healthy individuals contained detectable amounts of S-KIT. Next, we determined a total of 220 samples from 134 patients with haemopoietic disorders. A considerable number of patients with acute myeloid leukaemia (AML), especially those with more immature phenotypes (MO, M1 or M2) had elevated levels of serum S-KIT. Those levels decreased to the normal range after effective chemotherapy. In chronic myeloid leukaemia, patients with myeloid blastic crisis showed markedly elevated levels of serum S-KIT. In contrast, S-KIT levels decreased in cases with either acute or chronic lymphoid leukaemia. There was a tendency for patients with severe aplastic anaemia to show decreased levels, but it was not significant. In myelodysplastic syndrome, S-KIT levels appeared to vary by subsets, with higher concentration in more advanced forms of the disease. Although the functional role of S-KIT is not yet elucidated, these results suggest that the serum S-KIT levels may reflect the pathological states of various haematological disorders.

KW - CMK

KW - Haemopoietic disorders

KW - Human sera

KW - Soluble c-kit products

UR - http://www.scopus.com/inward/record.url?scp=0029046519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029046519&partnerID=8YFLogxK

M3 - Article

C2 - 7577639

AN - SCOPUS:0029046519

VL - 91

SP - 23

EP - 29

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -